Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Oncology (Williston Park, N.Y.)|January 18, 2005
Bcl-2 antisense therapy in multiple myelomaAsher A Chanan-KhanCurrent Oncology Reports|August 21, 2007
New treatments for chronic lymphocytic leukemiaAsher A Chanan-KhanJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Importance of achieving a complete response in multiple myeloma, and the impact of novel agentsAsher A Chanan-Khan, Sergio GiraltJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2008
Lenalidomide for the treatment of B-cell malignanciesAsher A Chanan-Khan, Bruce D ChesonThe Oncologist|September 4, 2007
Clinical impact of bortezomib in frontline regimens for patients with multiple myelomaRami Manochakian, Kena C Miller, Asher A Chanan-KhanBritish Journal of Haematology|July 13, 2010
Development of target-specific treatments in multiple myelomaAsher A Chanan-Khan, Ivan Borrello, Kelvin P Lee, et al.Journal of Experimental & Clinical Cancer Research : CR|January 26, 2010
Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell typesXiang Ling, Diane Calinski, Asher A Chanan-Khan, et al.Current Opinion in Oncology|September 5, 2009
Targeting the Bcl-2Mehul P Patel, Aisha Masood, Priya S Patel, et al.JCO Oncology Practice|February 12, 2020
Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel TherapiesRicardo D Parrondo, Sikander Ailawadhi, Taimur Sher, et al.Drug Safety|July 15, 2026
Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic LeukemiaSikander Ailawadhi, Elcin Omercikoglu, Aneel Paulus, et al.Pageof 9